| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | 263,4 k € | — | 261,0 k € | -1.1% | 263,9 k € | — | — | |||||||||||||||||
| Gross margin | 24,4 k € | -45.3% | 44,7 k € | -36.0% | 69,9 k € | -50.7% | 141,7 k € | -19.8% | 176,7 k € | +71.2% | 103,2 k € | -32.8% | 153,6 k € | -7.9% | 166,8 k € | -1.4% | 169,1 k € | +29.4% | 130,7 k € | +6.8% | 122,3 k € | +4.2% | 117,4 k € | -9.5% | 129,8 k € | -26.1% | 175,5 k € | +4.2% | 168,5 k € | -8.5% | 184,1 k € | +9.7% | 167,8 k € | +0.6% | 166,8 k € | |
| EBITDA | 23,5 k € | -44.1% | 42,0 k € | -37.6% | 67,3 k € | -51.5% | 138,8 k € | -19.8% | 173,1 k € | +74.1% | 99,4 k € | -33.7% | 150,0 k € | +10.9% | 135,2 k € | -17.5% | 163,9 k € | +30.7% | 125,4 k € | +6.6% | 117,7 k € | +4.1% | 113,1 k € | -10.1% | 125,8 k € | -26.2% | 170,5 k € | +8.2% | 157,5 k € | -9.1% | 173,4 k € | +9.4% | 158,4 k € | +1.4% | 156,2 k € | |
| Operating profit | 23,5 k € | -44.1% | 42,0 k € | -37.6% | 67,3 k € | -47.0% | 126,9 k € | -21.3% | 161,2 k € | +84.2% | 87,5 k € | -36.6% | 138,1 k € | +12.0% | 123,3 k € | -19.8% | 153,8 k € | +46.7% | 104,8 k € | +7.4% | 97,6 k € | +4.6% | 93,2 k € | -11.7% | 105,6 k € | -24.0% | 138,9 k € | +2.0% | 136,1 k € | -6.3% | 145,3 k € | +11.9% | 129,9 k € | +2.0% | 127,4 k € | |
| Profit/loss | 216,9 k € | +712.9% | 26,7 k € | -42.5% | 46,4 k € | -24.2% | 61,2 k € | -43.6% | 108,6 k € | +84.0% | 59,0 k € | -38.1% | 95,3 k € | -1.3% | 96,5 k € | -0.6% | 97,1 k € | +19.1% | 81,5 k € | +10.2% | 74,0 k € | -19.6% | 92,0 k € | +2.3% | 90,0 k € | -21.0% | 113,9 k € | +31.6% | 86,6 k € | -21.9% | 110,9 k € | +6.4% | 104,2 k € | +9.2% | 95,4 k € | |
| Equity | 1,2 M € | +22.7% | 957,1 k € | +2.9% | 930,4 k € | +5.3% | 884,0 k € | +7.4% | 822,8 k € | +15.2% | 714,3 k € | +9.0% | 655,3 k € | -49.3% | 1,3 M € | +8.1% | 1,2 M € | +8.8% | 1,1 M € | +7.1% | 1,0 M € | +7.8% | 951,5 k € | -3.0% | 980,7 k € | +10.1% | 890,8 k € | +1.6% | 876,9 k € | +11.0% | 790,3 k € | +19.2% | 663,2 k € | +18.6% | 559,0 k € | |
| Total assets | 1,2 M € | +2.4% | 1,2 M € | +17.4% | 990,8 k € | +7.9% | 917,9 k € | +7.4% | 855,0 k € | +13.0% | 756,9 k € | +0.3% | 754,6 k € | -44.2% | 1,4 M € | +8.0% | 1,3 M € | +9.2% | 1,1 M € | +4.8% | 1,1 M € | +3.9% | 1,1 M € | -1.4% | 1,1 M € | +6.0% | 1,0 M € | +12.4% | 895,4 k € | +8.4% | 826,0 k € | +13.1% | 730,4 k € | +13.0% | 646,1 k € | |
| Cash | 6,1 k € | -93.1% | 87,8 k € | -3.7% | 91,2 k € | -54.8% | 201,8 k € | -75.7% | 830,3 k € | +15.1% | 721,5 k € | +0.8% | 716,1 k € | -44.9% | 1,3 M € | +9.9% | 1,2 M € | +10.5% | 1,1 M € | +6.1% | 1,0 M € | +6.6% | 947,8 k € | +0.5% | 942,7 k € | +8.0% | 872,6 k € | +18.4% | 737,0 k € | +19.1% | 618,6 k € | +28.5% | 481,3 k € | +5.2% | 457,6 k € | |
| Debts | 18,0 k € | +124.9% | 8,0 k € | +2110.2% | 361,2 € | -98.9% | 33,9 k € | +5.4% | 32,2 k € | -0.5% | 32,3 k € | -63.7% | 89,1 k € | +78.6% | 49,9 k € | +9.0% | 45,8 k € | +16.4% | 39,3 k € | -35.9% | 61,3 k € | -37.0% | 97,3 k € | +13.2% | 86,0 k € | -25.9% | 115,9 k € | +526.5% | 18,5 k € | -48.1% | 35,7 k € | -46.6% | 66,8 k € | -23.0% | 86,8 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0,2 | 0,2 | 0,2 | 0,2 | ||||||||||||||||||
Private limited company · Kampenhout · incorporated on 02/04/1996
Private limited company profitable and well capitalised. Cash position declining (-93.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. VANHOOF - Dr. VAN BRANTEGHEM is a Private limited company incorporated in 1996. Its main activity is: General medical practice activities. Its registered office is in Kampenhout.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette